IL141899A0 - Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin - Google Patents

Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin

Info

Publication number
IL141899A0
IL141899A0 IL141899??A IL14189999A IL141899A0 IL 141899 A0 IL141899 A0 IL 141899A0 IL 14189999 A IL14189999 A IL 14189999A IL 141899 A0 IL141899 A0 IL 141899A0
Authority
IL
Israel
Prior art keywords
cyclosporin
pharmaceutical compositions
receptor antagonist
chemokine receptor
chemokine
Prior art date
Application number
IL141899??A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL141899A0 publication Critical patent/IL141899A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL141899??A 1998-09-18 1999-09-16 Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin IL141899A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98117697A EP1000626A1 (en) 1998-09-18 1998-09-18 Chemokine receptor antagonist and cyclosporin in combined therapy
PCT/EP1999/006844 WO2000016796A1 (en) 1998-09-18 1999-09-16 Chemokine receptor antagonist and cyclosporin in combined therapy

Publications (1)

Publication Number Publication Date
IL141899A0 true IL141899A0 (en) 2002-03-10

Family

ID=8232654

Family Applications (2)

Application Number Title Priority Date Filing Date
IL141899??A IL141899A0 (en) 1998-09-18 1999-09-16 Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin
IL141899A IL141899A (en) 1998-09-18 2001-03-08 Pharmaceutical preparations containing antagonist to the receptor of chemokine, together with cyclosporine

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141899A IL141899A (en) 1998-09-18 2001-03-08 Pharmaceutical preparations containing antagonist to the receptor of chemokine, together with cyclosporine

Country Status (23)

Country Link
US (1) US6902728B1 (ru)
EP (2) EP1000626A1 (ru)
JP (1) JP2003519082A (ru)
KR (1) KR100613950B1 (ru)
CN (1) CN1177613C (ru)
AR (1) AR021810A1 (ru)
AT (1) ATE227582T1 (ru)
AU (1) AU766595B2 (ru)
BR (1) BR9913846A (ru)
CA (1) CA2344370A1 (ru)
DE (1) DE69903964T2 (ru)
DK (1) DK1113811T3 (ru)
EA (1) EA003181B1 (ru)
EE (1) EE04705B1 (ru)
ES (1) ES2186411T3 (ru)
HK (1) HK1041225B (ru)
IL (2) IL141899A0 (ru)
NO (1) NO20011371L (ru)
PT (1) PT1113811E (ru)
SI (1) SI1113811T1 (ru)
UA (1) UA60379C2 (ru)
WO (1) WO2000016796A1 (ru)
ZA (1) ZA200101909B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259136B2 (en) 1999-04-30 2007-08-21 Amylin Pharmaceuticals, Inc. Compositions and methods for treating peripheral vascular disease
US6740636B2 (en) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
LT5132B (lt) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Nepeptidiniai ccr1 receptorių antagonistai derinyje su ciklosporinu a širdies transplanto atmetimui gydyti
ES2453592T3 (es) 2007-08-02 2014-04-08 Novimmune Sa Anticuerpos anti-RANTES y métodos de uso de los mismos
JP6733968B2 (ja) * 2015-08-31 2020-08-05 日立化成株式会社 腎移植後合併症を評価するための分子法
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI972433A0 (fi) * 1994-12-08 1997-06-06 Glaxo Group Ltd Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
CA2228379A1 (en) * 1995-08-09 1997-02-20 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
WO1998006703A1 (en) * 1996-08-14 1998-02-19 Warner-Lambert Company 2-phenyl benzimidazole derivatives as mcp-1 antagonists
WO1998006751A1 (en) * 1996-08-16 1998-02-19 Research Corporation Technologies, Inc. Mcp-3, rantes and mip-1alpha receptor antagonists

Also Published As

Publication number Publication date
WO2000016796A1 (en) 2000-03-30
IL141899A (en) 2007-12-03
EE04705B1 (et) 2006-10-16
JP2003519082A (ja) 2003-06-17
CN1177613C (zh) 2004-12-01
EP1113811B1 (en) 2002-11-13
EE200100159A (et) 2002-08-15
PT1113811E (pt) 2003-03-31
ATE227582T1 (de) 2002-11-15
CN1319021A (zh) 2001-10-24
HK1041225A1 (en) 2002-07-05
BR9913846A (pt) 2001-06-05
ES2186411T3 (es) 2003-05-01
AU766595B2 (en) 2003-10-16
KR20010075060A (ko) 2001-08-09
EP1113811A1 (en) 2001-07-11
AR021810A1 (es) 2002-08-07
NO20011371D0 (no) 2001-03-16
DE69903964T2 (de) 2003-03-27
EA003181B1 (ru) 2003-02-27
EP1000626A1 (en) 2000-05-17
DE69903964D1 (en) 2002-12-19
KR100613950B1 (ko) 2006-08-18
CA2344370A1 (en) 2000-03-30
US6902728B1 (en) 2005-06-07
DK1113811T3 (da) 2003-03-10
HK1041225B (zh) 2005-04-22
NO20011371L (no) 2001-03-16
AU6191499A (en) 2000-04-10
UA60379C2 (ru) 2003-10-15
ZA200101909B (en) 2001-09-11
SI1113811T1 (en) 2003-04-30
EA200100366A1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
HUP0103796A3 (en) Neuropeptide y5 receptor antagonists and medicaments containing them
HUP0102658A3 (en) Pharmaceutical composition containing opioid agonist and antagonist combination
HUP0100626A3 (en) Kappa receptor opioid tetra peptides and pharmaceutical compositions comprising thereof
IL135797A (en) Thrombin receptor antagonists and pharmaceutical compositions comprising them
EP1000031A4 (en) VITRONECTIN RECEPTOR ANTAGONISTS
AU5274499A (en) Therapeutic chemokine receptor antagonists
HUP9904363A3 (en) Piperidine ether muscarinic antagonists and pharmaceutical compositions containing them
HUP0201372A3 (en) Pharmaceutical compositions comprising cyclosporin
IL137990A0 (en) A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
HUP0302382A3 (en) Il-8 receptor antagonists and pharmaceutical compositions containing them
IL144413A0 (en) Pharmaceutical compositions comprising a tnf antagonist
SI1237559T1 (sl) Farmacevtska kombinacija vsebujoca p2t receptor antagonist in melagatran
IL135189A0 (en) Vitronectin receptor antagonist
IL135188A0 (en) Vitronectin receptor antagonist
IL138576A0 (en) A novel interleukin-1 receptor antagonist and uses thereof
HUP0302003A3 (en) Il-8 receptor antagonists and pharmaceutical compositions containing them
GB2363572B (en) Pharmaceutical composition containing cyclosporin
GB9820014D0 (en) Receptor antagonists and uses thereof
HUP0002929A3 (en) 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
HUP0201300A3 (en) Il-8 receptor antagonist imidazoidinylidene-2-imino derivatives and pharmaceutical compositions containing them
HUP0500079A3 (en) Chemokine receptor antagonists, their use and pharmaceutical compositions containing them
EG24025A (en) Vitronectin receptor antagonist
HUP0302614A3 (en) Il-8 receptor antagonists and pharmaceutical compositions containing them
IL141899A0 (en) Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin
HUP0202710A3 (en) Vitronectin receptor antagonists, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed